Seelos Therapeutics (NASDAQ:SEEL) filed for resale by investors of up to ~3.4M shares.
The ~3.4M shares are issuable upon exercise of outstanding warrants to purchase shares, issued by us to the selling stockholders on January 30, 2024.
The company registering the resale of the shares as required by the securities purchase agreement.
The company will not receive any of the proceeds from the shares sold by the selling stockholders, other than any proceeds from any cash exercise of warrants.
The stock is marginally higher 0.25% to $1.00 on Monday during pre-market hours of trading.